Citation: T. Cardillo et al., THE ABILITY OF ANTITRANSFERRIN RECEPTOR ANTIBODIES TO INHIBIT IRON UPTAKE IN TUMOR-CELLS APPEARS TO BE RELATED TO THE INITIAL CELL-SURFACE DENSITY THE RECEPTOR, The FASEB journal, 9(4), 1995, pp. 1045-1045
Citation: J. Kovar et al., INHIBITION OF HUMAN TUMORS IN-VITRO BY SYNERGISTIC ANTITRANSFERRIN RECEPTOR MONOCLONAL-ANTIBODIES AND DEFEROXAMINE, The FASEB journal, 9(4), 1995, pp. 1045-1045
Authors:
KEMP J
CARDILLO T
KERBERG E
WEINER G
NAUMANN P
Citation: J. Kemp et al., IRON DEPRIVATION TREATMENT OF MURINE LYMPHOMA IN-VITRO AND IN-VIVO - A COMPARISON OF PROTOCOLS USING EITHER ONE OR 2 IGG MONOCLONAL ANTITRANSFERRIN RECEPTOR ANTIBODIES WITH THE HYDROXYETHYL STARCH-DEFEROXAMINE, The FASEB journal, 9(3), 1995, pp. 206-206
Citation: J. Kemp et al., INHIBITION OF TUMOR-GROWTH IN-VITRO AND IN-VIVO BY COMBINED TREATMENTWITH DEFEROXAMINE AND IGG MABS AGAINST THE TRANSFERRIN RECEPTOR, The FASEB journal, 8(4), 1994, pp. 10000504-10000504
Citation: P. Naumann, THE RESTORATION RAKE-HERO - TRANSFORMATIO NS IN SEXUAL UNDERSTANDING IN 17TH-CENTURY - WEBER,HM, Anglia, 112(1-2), 1994, pp. 233-238
Authors:
CARDILLO T
SMITH K
STEWART B
NAUMANN P
KEMP J
Citation: T. Cardillo et al., THE GROWTH INHIBITORY EFFECTS OF ANTITRANSFERRIN RECEPTOR ANTIBODIES APPEAR TO BE RELATED TO THE INITIAL CELL-SURFACE DENSITY OF TRANSFERRIN RECEPTORS, The Journal of immunology, 150(8), 1993, pp. 143-143